LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 6.06 | 84.90 | 713 | 365 | 1.9510 | 1.7470 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.77 | 84.90 | 796 | 411 | 1.9356 | 1.6732 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.77 | 84.90 | 783 | 411 | 1.9040 | 1.6540 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.47 | 84.90 | 867 | 447 | 1.9377 | 1.6354 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 9.47 | 84.90 | 859 | 447 | 1.9199 | 1.6252 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.18 | 84.90 | 920 | 492 | 1.8686 | 1.5591 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 11.18 | 84.90 | 928 | 492 | 1.8848 | 1.5679 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.88 | 84.90 | 1001 | 531 | 1.8851 | 1.5417 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.88 | 84.90 | 7 | 531 | 0.0132 | -0.6107 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.88 | 84.90 | 982 | 531 | 1.8493 | 1.5234 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.58 | 84.90 | 109 | 663 | 0.1643 | 0.0879 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.58 | 84.90 | 1052 | 663 | 1.5858 | 1.3364 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.58 | 84.90 | 3 | 663 | 0.0045 | -0.6760 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.58 | 84.90 | 1027 | 663 | 1.5481 | 1.3175 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.29 | 84.90 | 266 | 766 | 0.3469 | 0.4329 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.29 | 84.90 | 1106 | 766 | 1.4423 | 1.2445 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.29 | 84.90 | 14 | 766 | 0.0183 | -0.4331 | MN20160318_Q02 | D15 |